Literature DB >> 9814833

Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases.

M Hurme1, N Lahdenpohja, S Santtila.   

Abstract

Cytokines are proteins that regulate immune and inflammatory reactions as well as haematopoiesis. This group of molecules is very heterogeneous including, for example, several interleukins (IL), tumour necrosis factors (TNF) and colony-stimulating factors (CSF). The cytokines participating in the regulation of the inflammatory response are IL-1, IL-1 receptor antagonist (IL-1RA), IL-6, IL-10 and TNF. Functionally they can be divided into proinflammatory (IL-1, IL-6, TNF) and anti-inflammatory (IL-1RA, IL-10) molecules. There is evidence that the inflammatory response must be finely tuned: too strong a response causes the various adverse effects associated with infectious and autoimmune diseases, while a weak inflammatory response attenuates the subsequent immune response. It has now been demonstrated that several of the cytokine genes are polymorphic. In this review we describe the polymorphisms of the two inflammatory cytokines, IL-1 and IL-10, and their significance in various diseases of autoimmune or inflammatory nature.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9814833     DOI: 10.3109/07853899809002488

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  22 in total

1.  Polymorphisms in tumor necrosis factor and other cytokines as risks for infectious diseases and the septic syndrome.

Authors:  Julian Knight
Journal:  Curr Infect Dis Rep       Date:  2007-10       Impact factor: 3.725

Review 2.  Ethnic differences in gastric cancer genetic susceptibility: allele flips of interleukin gene.

Authors:  Juwon Kim; Yoonjung Kim; Kyung-A Lee
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

3.  Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies.

Authors:  L G Rider; C M Artlett; C B Foster; A Ahmed; T Neeman; S J Chanock; S A Jimenez; F W Miller
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

4.  Innate Immune System Gene Polymorphisms in Women with Vulvovaginal Infections.

Authors:  Mehmet R Genç; Andrew Onderdonk; Steven S Witkin
Journal:  Curr Infect Dis Rep       Date:  2004-12       Impact factor: 3.725

5.  Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection.

Authors:  R Rad; A Dossumbekova; B Neu; R Lang; S Bauer; D Saur; M Gerhard; C Prinz
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

6.  Interleukin-1 cluster gene polymorphisms in childhood IgA nephropathy.

Authors:  Won Ho Hahn; Byoung Soo Cho; Sung Do Kim; Su Kang Kim; Sungwook Kang
Journal:  Pediatr Nephrol       Date:  2009-03-12       Impact factor: 3.714

7.  Environmental factors and not genotype influence the plasma level of interleukin-1 receptor antagonist in normal individuals.

Authors:  H Cullup; P G Middleton; G Duggan; J S Conn; A M Dickinson
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

8.  Polymorphisms in two genes, IL-1B and ACE, are associated with erythropoietin resistance in Korean patients on maintenance hemodialysis.

Authors:  Kyung Hwan Jeong; Tae Won Lee; Chun Gyoo Ihm; Sang Ho Lee; Ju Young Moon
Journal:  Exp Mol Med       Date:  2008-04-30       Impact factor: 8.718

9.  Association of IL-1beta, IL-1ra, and TNF-alpha gene polymorphisms in childhood nephrotic syndrome.

Authors:  Sung-Do Kim; Jae-Man Park; Il-Soo Kim; Kang-Duk Choi; Byung-Cheol Lee; Sang-Ho Lee; Seung-Jae Hong; Sheng-Yu Jin; Hee-Jae Lee; Mee-Suk Hong; Joo-Ho Chung; Tae-Won Lee; Chun-Gyoo Ihm; Byoung-Soo Cho
Journal:  Pediatr Nephrol       Date:  2004-02-03       Impact factor: 3.714

Review 10.  Targeting interleukin-1 in heart disease.

Authors:  Benjamin W Van Tassell; Stefano Toldo; Eleonora Mezzaroma; Antonio Abbate
Journal:  Circulation       Date:  2013-10-22       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.